Dr. Peter Francis
I've won the following awards
Top Retinal Surgeon, National
Technology and Innovation Award, OHSU
Honorary Lecturership, Royal College of Ophthalmologists
Who's who in America, Who's Who in American Medicine
Best research at Annual Congress of Ophthalmology, The Fould's Trophy
National research award to the Best up and coming researcher, BUPA Foundation National Research Prize
Competitive award providing salary and expenses, TFC Frost Scholarship
The Royal Society, Paliament Award, The Royal Society Parliament
Competitive award for conference travel, Pharmacia ARVO travel award
Competitive award for conference travel, European Union Travelling Fellowship
Welcome Trust Clinician Scientist Fellowship, Welcome Trust Clinician Scientist Fellowship
Competitive award for conference travel, St. George's Research Award
Awarded for the best Bachelors degree research, Virchow Research Award
Awarded for the best overall medical school research project, Altounyan Prize
Wessex Medical School Trust Bursary, Wessex Medical School Trust Bursary
Technology and Innovation Awards 2009-2011
Best up-and-coming medical researcher in the UK 2002
HealthTap Founding Doctor
Risk assessment model for development of advanced age-related macular degeneration.
Arch. Ophthalmol., Dec;129(12):1543-50 (2011)
Prospective randomized controlled trial of combination ranibizumab (Lucentis) and bromfenac (Xibrom) for neovascular age-related macular degeneration: a pilot study.
Retina (Philadelphia, Pa.)., Mar;32(3):417-23 (2012)
Rhesus monkeys and humans share common susceptibility genes for age-related macular disease.
Hum. Mol. Genet., Sep;17(17):2673-80 (2008)
Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
J. Med. Genet., May;46(5):300-7 (2009)
Subretinal transplantation of forebrain progenitor cells in nonhuman primates: survival and intact retinal function.
Invest. Ophthalmol. Vis. Sci., Jul;50(7):3425-31 (2009)
Progression of geographic atrophy and genotype in age-related macular degeneration.
Ophthalmology., Aug;117(8):1554-9, 1559.e1 (2010)
Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Arch. Ophthalmol., Jan;129(1):30-9 (2011)
Acute macular outer retinopathy (AMOR): a reappraisal of acute macular neuroretinopathy using multimodality diagnostic testing.
Arch. Ophthalmol., Mar;129(3):365-8 (2011)
Surgical approaches to gene and stem cell therapy for retinal disease.
Hum. Gene Ther., May;22(5):531-5 (2011)
Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family.
Hum. Mol. Genet., Dec;12(24):3315-23 (2003)
Genetics of age-related macular degeneration.
Ophthalmol Clin North Am., Dec;16(4):567-74 (2003)
Gene therapy and control of angiogenesis.
Ophthalmol Clin North Am., Dec;16(4):575-82 (2003)
Stop mutations in exon 6 of the choroideremia gene, CHM, associated with preservation of the electroretinogram.
Arch. Ophthalmol., Aug;123(8):1146-9 (2005)
Genetic and phenotypic heterogeneity in pattern dystrophy.
Br J Ophthalmol., Sep;89(9):1115-9 (2005)
The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration.
Hum. Hered., 63(3-4):212-8 (2007)
Update on the role of genetics in the onset of age-related macular degeneration.
Clin Ophthalmol., 5:1127-33 (2011)
The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).
Trans Am Ophthalmol Soc., Dec;109:115-56 (2011)
Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian population.
Mol. Vis., 14:1395-400 (2008)
The genetics of childhood cataract.
J. Med. Genet., Jul;37(7):481-8 (2000)
Visual outcome in patients with isolated autosomal dominant congenital cataract.
Ophthalmology., Jun;108(6):1104-8 (2001)